Studying the association between early tau deposition and atrophy in specific brain areas is therefore of particular interest to identify brain regions whose atrophy could be specific to tau pathology related to AD and ultimately detect individuals who will develop AD symptoms in the future.10 The gene discussed is MAPT; the disease is Alzheimer disease.